GKB (GKB) fundamentals
GKB is a listed company, part of the Medical Equipment sector, listed on the NSE as GKB (ISIN INE265D01015). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What GKB does
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Valuation and market data
| Last close | ₹64.80 |
|---|---|
| Market capitalisation | ₹-28 crore |
| Enterprise value | ₹-24 crore |
| P/E (TTM) | 0.00 |
| Price to book | -0.51 |
| Price to sales (TTM) | -0.10 |
| Book value per share | ₹-128.25 |
| Dividend yield | 0.00% |
| Sector | Medical Equipment |
| Industry | — |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹32 crore | ₹-4 crore | ₹-4 crore | -7.08 |
| Mar 2025 | ₹35 crore | ₹-6 crore | ₹-6 crore | -12.12 |
| Mar 2024 | ₹33 crore | ₹-3 crore | ₹-3 crore | -6.78 |
| Mar 2023 | ₹30 crore | ₹-3 crore | ₹-3 crore | -5.72 |
| Mar 2022 | ₹29 crore | ₹-2 crore | ₹-2 crore | -4.58 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 51.1% |
|---|---|
| Foreign institutions (FII) | 1.8% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 47.1% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.